Trasis

𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻] 𝗚𝗠𝗣-𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝗥𝗮𝗱𝗶𝗼𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗼𝗳 [𝟭𝟴𝗙]𝗦𝘆𝗻𝗩𝗲𝘀𝗧-𝟭 𝗳𝗼𝗿 𝗣𝗘𝗧 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗼𝗳 𝗦𝘆𝗻𝗮𝗽𝘁𝗶𝗰 𝗩𝗲𝘀𝗶𝗰𝗹𝗲 𝗚𝗹𝘆𝗰𝗼𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝟮𝗔 (𝗦𝗩𝟮𝗔) Discover how GMP-compliant automated radiosynthesis of [18F]SynVesT-1 advances PET imaging of synaptic vesicle glycoprotein 2A (SV2A), a crucial biomarker for studying synaptic density and neurodegenerative disorders. Read the full publication here: https://lnkd.in/gaFZzgn3 #SynVesT1 #SV2A #PETImaging #NeurodegenerativeDiseases #AutomatedRadiosynthesis #GMPCompliant #Radiopharmacy #Trasis

🚀  Trasis proudly represented Wallonia at the Healthcare+ Expo Taiwan, one of Asia's leading medtech trade shows. Thank you Wallonia Export & Investment Agency for the opportunity! This was a unique chance to showcase our innovative technologies and connect with key players in the Asian market. 👉 Learn more in the article from Inside Taïwan: https://lnkd.in/emjUmvgq

🚀 𝗧𝗿𝗮𝘀𝗶𝘀 𝗶𝘀 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗧𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗥𝗮𝗱𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 𝗶𝗻 𝗔𝗺𝘀𝘁𝗲𝗿𝗱𝗮𝗺!🚀 This prestigious event brings together the brightest minds and cutting-edge innovations in the field of #Radiopharmacy. 👨🔬 Meet our experts, Charles Vriamont and Antoine B. , at booth #3! With their extensive knowledge and experience, they are eager to share insights, discuss groundbreaking advancements, and explore the future of radiopharmaceuticals with you. #Trasis #Innovation #Pharmaceuticals #TRPEU

[𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻] 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗼𝗳 𝗮 𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗲 [𝟲𝟴𝗚𝗮]𝗚𝗮-𝗙𝗔𝗣𝗜-𝟰𝟲 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝗦𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗦𝘂𝗶𝘁𝗮𝗯𝗹𝗲 𝗳𝗼𝗿 𝗠𝘂𝗹𝘁𝗶-𝗘𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗼𝗳 𝗚𝗲𝗿𝗺𝗮𝗻𝗶𝘂𝗺-𝟲𝟴/𝗚𝗮𝗹𝗹𝗶𝘂𝗺-𝟲𝟴 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗼𝗿𝘀   Learn about versatile automated synthesis method for [68Ga]Ga-FAPI-46, optimized for multi-elutions from Germanium-68/Gallium-68 generators. This innovation enhances production efficiency for radiopharmaceutical applications.   Read the full details here: https://lnkd.in/gRF_gcQa   #68GaFAPI46 #Gallium68 #Germanium68 #AutomatedSynthesis #Radiopharmacy #InnovationInHealthcare #NuclearMedicine #Trasis  

🍁 𝗛𝗮𝗽𝗽𝘆 𝗧𝗵𝗮𝗻𝗸𝘀𝗴𝗶𝘃𝗶𝗻𝗴 𝘁𝗼 𝗮𝗹𝗹! 🍁 Thanksgiving is a time to gather and celebrate with family, and at Trasis, we’re grateful for our own family – our family of synthesizers. Together, we work to develop and produce the radiopharmaceuticals of today and tomorrow, pushing forward patient care and advancing health worldwide. From our family to yours, we wish you a wonderful Thanksgiving filled with gratitude, connection, and joy! #Thanksgiving #TrasisFamily #Radiopharmaceuticals #PatientCare #Innovation #AllinOneFamily

[𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻] [𝟭𝟴𝗙]𝗥𝗮𝗱𝗶𝗼𝗹𝗮𝗯𝗲𝗹𝗶𝗻𝗴 𝗮𝗻𝗱 𝗘𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗮𝗻 𝗔𝗠𝗗𝟯𝟰𝟲𝟱 𝗗𝗲𝗿𝗶𝘃𝗮𝘁𝗶𝘃𝗲 𝗳𝗼𝗿 𝗣𝗘𝗧 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗼𝗳 𝗖𝗫𝗖𝗥𝟰 𝗶𝗻 𝗮 𝗠𝗼𝘂𝘀𝗲 𝗕𝗿𝗲𝗮𝘀𝘁 𝗧𝘂𝗺𝗼𝗿 𝗠𝗼𝗱𝗲𝗹   Explore the [18F]radiolabeling of an AMD3465 derivative for PET imaging of CXCR4, providing valuable insights into breast tumor models and enabling advanced molecular imaging for cancer research.   Read more here: https://lnkd.in/gMpptmx7   #CXCR4 #BreastCancerResearch #PETImaging #18FRadiolabeling #MolecularImaging #CancerResearch #Radiopharmacy #Trasis

🌟  𝗧𝗿𝗮𝘀𝗶𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗧𝗥𝗣 𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝘂𝗺𝗺𝗶𝘁 𝗶𝗻 𝗔𝗺𝘀𝘁𝗲𝗿𝗱𝗮𝗺!🌟 We are excited to announce that Trasis will be attending the Targeted Radiopharmaceuticals (TRP) Europe Summit from December 3 to December 5, 2024, in Amsterdam, Netherlands! Come visit us at 𝗕𝗼𝗼𝘁𝗵 #𝟯. Don't miss the opportunity to explore the latest trends, discover innovative solutions, and network with key leaders in the radiopharmaceutical industry. 𝗦𝗲𝗲 𝘆𝗼𝘂 𝗶𝗻 𝗔𝗺𝘀𝘁𝗲𝗿𝗱𝗮𝗺! #Trasis #TRPeurope #Radiopharmaceuticals #Innovation #Healthcare #Amsterdam2024

𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗱𝗲 𝗹’𝗮𝗻𝗻𝗲́𝗲 𝟮𝟬𝟮𝟰 – 𝗗𝗲𝘂𝘅 𝗪𝗮𝗹𝗹𝗼𝗻𝘀, 𝗰𝗵𝗮𝗺𝗽𝗶𝗼𝗻𝘀 𝗱𝗲 𝗹𝗮 𝗺𝗲́𝗱𝗲𝗰𝗶𝗻𝗲 𝗻𝘂𝗰𝗹𝗲́𝗮𝗶𝗿𝗲 ! Découvrez l’interview exclusive de Gauthier Philippart, réalisée dans le cadre des Managers de l’année 2024 et signée par l’excellente plume de Frédéric Brebant, journaliste chez 𝘛𝘳𝘦𝘯𝘥𝘴-𝘛𝘦𝘯𝘥𝘢𝘯𝘤𝘦𝘴. Un article fascinant qui nous plonge dans le passé et retrace l’évolution de Trasis, de ses débuts à aujourd’hui ! N'oubliez pas de 𝘃𝗼𝘁𝗲𝗿 pour nos deux finalistes avant le 24 novembre pour les propulser vers la victoire ! C’est par ici : https://lnkd.in/eK53SPfN #ManagerDeLAnnée #MédecineNucléaire #Leadership #Trasis #VotePublic #TrendsTendances #Innovation ----- 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗼𝗳 𝘁𝗵𝗲 𝗬𝗲𝗮𝗿 𝟮𝟬𝟮𝟰 – 𝗧𝘄𝗼 𝗪𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗵𝗮𝗺𝗽𝗶𝗼𝗻𝘀 𝗶𝗻 𝗡𝘂𝗰𝗹𝗲𝗮𝗿 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲! Discover the exclusive interview with Gauthier Philippart, conducted for the 2024 Manager of the Year awards and written by the talented Frédéric Brebant, journalist at 𝑇𝑟𝑒𝑛𝑑𝑠-𝑇𝑒𝑛𝑑𝑎𝑛𝑐𝑒𝑠 A fascinating article that dives into the past and traces Trasis’s evolution from its beginnings to today! Don’t forget to vote for our two finalists by November 24 to help propel them to victory! Vote here: https://lnkd.in/eK53SPfN #ManagerOfTheYear #NuclearMedicine #Leadership #Trasis #PublicVote #TrendsTendances #Innovation

✨ 𝗧𝗿𝗮𝘀𝗶𝘀 𝗲𝘀𝘁 𝗵𝗼𝗻𝗼𝗿𝗲́ 𝗱’𝗲̂𝘁𝗿𝗲 𝘀𝗲́𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝗻𝗲́ 𝗽𝗼𝘂𝗿 𝗹𝗲 𝗽𝗿𝗲𝘀𝘁𝗶𝗴𝗶𝗲𝘂𝘅 𝗰𝗼𝗻𝗰𝗼𝘂𝗿𝘀 𝗱𝘂 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗱𝗲 𝗹’𝗮𝗻𝗻𝗲́𝗲, 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲́ 𝗽𝗮𝗿 𝙏𝙧𝙚𝙣𝙙𝙨-𝙏𝙚𝙣𝙙𝙖𝙣𝙘𝙚𝙨! Un prix qui récompense des leaders d’entreprise au parcours exceptionnel, capables d’inspirer par leurs réalisations et leur vision. Nos cofondateurs, Gauthier Philippart et Jean-Luc Morelle, figurent parmi les finalistes de cette 40e édition ! 𝗘𝗻𝘃𝗶𝗲 𝗱𝗲 𝗹𝗲𝘀 𝘀𝗼𝘂𝘁𝗲𝗻𝗶𝗿 𝗽𝗼𝘂𝗿 𝗹𝗲𝘀 𝗰𝗼𝗻𝗱𝘂𝗶𝗿𝗲 𝗮̀ 𝗹𝗮 𝘃𝗶𝗰𝘁𝗼𝗶𝗿𝗲?  C'est possible! En plus des évaluations du jury, les votes du public comptent dans la note finale. Alors ne ratez pas l'occasion de soutenir leur engagement et leurs efforts en votant pour eux ici 👉 https://lnkd.in/eK53SPfN ⏰ Les votes sont ouverts jusqu’au 𝟮𝟰 𝗻𝗼𝘃𝗲𝗺𝗯𝗿𝗲 𝟮𝟬𝟮𝟰, alors ne tardez pas ! Rendez-vous pour la grande annonce des gagnants lors de la soirée du 8 janvier 2025. Merci d'avance à tous pour votre soutien ! #ManagerDeLAnnée #Leadership #Innovation #Trasis #VotePublic #TrendsTendances #Entrepreneuriat ----- ✨ 𝗧𝗿𝗮𝘀𝗶𝘀 𝗶𝘀 𝗵𝗼𝗻𝗼𝗿𝗲𝗱 𝘁𝗼 𝗯𝗲 𝘀𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗽𝗿𝗲𝘀𝘁𝗶𝗴𝗶𝗼𝘂𝘀 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗼𝗳 𝘁𝗵𝗲 𝗬𝗲𝗮𝗿 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻, 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗲𝗱 𝗯𝘆 𝑻𝒓𝒆𝒏𝒅𝒔-𝑻𝒆𝒏𝒅𝒂𝒏𝒄𝒆𝒔! An award that celebrates business leaders with exceptional paths, who inspire through their achievements and vision. Our co-founders, Gauthier Philippart and Jean-Luc Morelle, are among the finalists for this 40th edition! 𝗪𝗮𝗻𝘁 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝘁𝗵𝗲𝗺 𝗼𝗻 𝘁𝗵𝗲𝗶𝗿 𝗷𝗼𝘂𝗿𝗻𝗲𝘆 𝘁𝗼 𝘃𝗶𝗰𝘁𝗼𝗿𝘆? You can! Alongside the jury evaluations, the public vote also contributes to the final score. Don’t miss the chance to support their commitment and efforts by voting for them here: 👉 https://lnkd.in/eK53SPfN ⏰ Voting is open until November 24, 2024, so don’t delay! Join us for the announcement of the winners at the event on January 8, 2025. Thank you in advance for your support! #ManagerOfTheYear #Leadership #Innovation #Trasis #PublicVote #TrendsTendances #Entrepreneurship

𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝘁𝗵𝗲 𝘂𝘀𝗲 𝗼𝗳 𝘆𝗼𝘂𝗿 𝗚𝗮-𝟲𝟴 𝗜𝗥𝗘-𝗘𝗹𝗶𝘁 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗼𝗿𝘀! By connecting two generators directly to our AllinOne Mini synthesizer, we provide the winning combination for smooth, continuous operations while maximizing each generator's full capacity. Thank you to IRE – IRE ELiT for this promising collaboration, which we hope Ga-68 users will enjoy! #NuclearMedicine #Gallium68 #Innovation #Radiopharmacy #Collaboration #Trasis